Skip to main content
See every side of every news story
Published loading...Updated

FDA proposes allowing sunscreen ingredient already used in Europe and Asia

Bemotrizinol offers broad-spectrum UVA/UVB protection, is photostable, has low skin absorption, and is safe for children 6 months and older, FDA said in a Dec. 11 proposal.

  • On December 11, 2025, the U.S. Food and Drug Administration proposed adding bemotrizinol as a permitted sunscreen active ingredient that protects against UVA and UVB and is more photostable than many filters.
  • The United States currently approves 16 main sunscreen filters compared with about 30 in Europe, and the last new ingredient was added in 1999, with the FDA acknowledging slow progress.
  • DSM Nutritional Products LLC submitted an OTC Monograph Order Request to add bemotrizinol at concentrations up to 6 percent, and the FDA proposed the change through the OTC monograph administrative order process, seeking public comment.
  • If finalized, the ingredient would be considered safe for adults and children 6 months and older; Ben Nichols, FDA spokesman, said the agency expects a final order next summer or fall with products sold by late 2026.
  • Dermatologists and formulators say bemotrizinol is photostable and less irritating, enabling lighter textures and improving tolerance for sensitive skin.
Insights by Ground AI

70 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

NBC Dallas-Fort Worth broke the news in Fort Worth, United States on Thursday, December 11, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal